Peptide 'glow up' stacks: separating TikTok hype from actual data

What did @alex.optimize actually say?

In a 3.4 million-view TikTok, @alex.optimize named five compounds as their top picks for a pre-summer physical transformation: GHK-Cu, Tesamorelin (called "Tessa"), NAD+, BPC-157, and semaglutide (called "Retta," almost certainly short for Ozempic's brand cousin, Rybelsus, or possibly Mounjaro's tirzepatide). The framing was casual and aspirational, promising glowing skin, a flat belly, gut health, cellular energy, and a physique like a "Greek statue." They also promoted a peptide-stacking guide delivered via DM.

The pitch was smooth. But mixing FDA-approved GLP-1 drugs, compounded peptides, and a supplement like NAD+ into one breezy "glow up stack" papers over some real regulatory and safety distinctions that viewers deserve to know about.

Does the science back this up?

Partially, and unevenly. GHK-Cu has legitimate published data on skin biology. Tesamorelin has FDA approval for a specific population. NAD+ precursors have interesting but far-from-settled human evidence. BPC-157 has almost no human trial data. And "Retta" is doing serious pharmacological work that a TikTok list dramatically undersells.

GHK-Cu (copper peptide) has been studied in wound healing and skin aging contexts. Pickart and Margolina (2018, Biomolecules) reviewed its role in collagen synthesis stimulation and antioxidant activity, concluding effects are real but most evidence is in vitro or small trials. Tesamorelin's visceral fat reduction is documented in HIV-associated lipodystrophy patients (Falutz et al., 2010, New England Journal of Medicine), but that population is not most TikTok viewers. NAD+ precursor supplementation (NMN/NR) shows modest metabolic signals in humans per Yoshino et al. (2021, Science), but "vibrating high at a cellular level" is not how researchers describe it. BPC-157 remains almost entirely rodent data.

What did they get wrong, and what did they get right?

The GHK-Cu call is their strongest moment. Calling it "the beauty peptide" is simplified but directionally correct. The collagen synthesis claim has real mechanistic backing, even if clinical proof in healthy humans is thinner than the creator implied.

Tesamorelin's visceral fat effect is real, but the context erasure is a problem. This is an FDA-approved drug studied in a specific disease population. Presenting it as a general belly-fat solution skips over the fact that off-label compounded tesamorelin exists in a different regulatory category entirely.

Calling NAD+ a peptide is flat-out wrong. NAD+ is a coenzyme, not a peptide. Grouping it in a "peptide stack" is a category error, and "vibrating high" is wellness-speak with no clinical grounding.

BPC-157 for gut health has rodent support (Sikiric et al., 2016, Current Pharmaceutical Design), but zero robust human RCT data. Saying it's "great for gut health" as a fact to 3.4 million people overstates the evidence significantly.

"Retta" as a Greek-statue drug is the biggest misfire. GLP-1 receptor agonists like semaglutide are serious medications with documented side effects including nausea, pancreatitis risk, and muscle mass loss. A TikTok list framing is not appropriate context for a drug in this class.

What should you actually know?

These are not equivalent compounds. One is a topical or injectable copper peptide with cosmetic applications. One is a regulated prescription drug with a defined FDA indication. One isn't even a peptide. Stacking them without clinical oversight isn't biohacking, it's guessing with your endocrine system and gut lining.

The "comment guide for a DM" mechanic is a common funnel to sell courses or products. That doesn't mean the information is wrong, but it means there's a commercial incentive shaping what gets included and what gets left out.

If you're curious about any of these compounds, the conversation starts with a licensed clinician who can review your labs, your goals, and your health history. Compounded peptides in particular exist in a regulatory gray zone where quality control varies significantly by pharmacy. GLP-1 drugs require a prescription and appropriate medical supervision. None of this is a "stack" you self-assemble from a TikTok DM guide.